Do obesity and insulin resistance increase hepcidin and reduce intestinal iron absorption and release?

Obesity and insulin resistance establish a chronic, low-grade inflammatory environment that directly alters systemic iron homeostasis. This metabolic state drives elevated levels of the liver-derived peptide hormone hepcidin, leading to impaired dietary iron utilization and restricted cellular iron mobilization.

Clinical evidence

• Clinical and epidemiological studies demonstrate a strong, positive correlation between obesity, metabolic syndrome, and elevated serum hepcidin levels.
• In comparative clinical trials, obese cohorts exhibit significantly higher baseline serum hepcidin levels than lean controls, which scale proportionally with the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), visceral adiposity index, and serum ferritin.
• Interventions that reduce adipose tissue mass or systemic inflammation, such as hypocaloric diets, successfully reduce circulating C-reactive protein (CRP) and lower circulating hepcidin, confirming the metabolic dependency of this pathway.

Mechanistic pathways

• Inflammatory signaling: Adipose tissue expansion triggers chronic low-grade inflammation, upregulating systemic interleukin-6 (IL-6).
• Hepcidin transcription: Circulating IL-6 binds to its receptor on hepatocytes, activating the JAK-STAT3 signaling pathway. Phosphorylated STAT3 translocates to the nucleus and binds directly to the hepcidin promoter, stimulating its transcription.
• Ferroportin degradation: Systemic hepcidin binds to ferroportin, the sole cellular iron exporter present on the basolateral membrane of duodenal enterocytes, macrophages, and hepatocytes. This binding triggers rapid ubiquitination of the ferroportin cytoplasmic loop, leading to clathrin-mediated endocytosis and lysosomal degradation.
• Sequestration and impaired absorption: The loss of membrane ferroportin traps dietary iron within enterocytes and prevents macrophage iron recycling from senescent erythrocytes. Secondarily, intracellular iron retention in enterocytes downregulates apical divalent metal transporter 1 (DMT1) expression via the inhibition of hypoxia-inducible factor 2-alpha (HIF-2α) pathways, further suppressing dietary iron absorption.

Bottom line

• Obesity and insulin resistance upregulate systemic hepcidin via adipose-driven IL-6 and the hepatic JAK-STAT3 pathway, causing functional iron deficiency by triggering the internalization and degradation of the cellular iron exporter ferroportin.